Caption Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Caption Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-75,000	Closed	-$3.94M	–	1375
2020 Q3	$3.94M	Buy	+75,000	New	+$3.1M	0.09%	262
2020 Q2	–	Sell	-98,640	Closed	-$2.68M	–	1281
2020 Q1	$2.68M	Buy	+98,640	New	+$2.75M	0.15%	188

Caption Management's MNTA Position: Q4 2020 in Review

Caption Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 75,000 shares — an estimated $3.94M sold.

Caption Management first reported a position in MNTA in Q1 2020 and held it in 2 quarters. The position peaked at $3.94M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Caption Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Caption Management sold 75,000 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $3.94M.
Caption Management first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2020 and held it in 2 quarters.
Caption Management's Momenta Pharmaceuticals, Inc. position peaked at $3.94M in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Caption Management's 13F filing for Q4 2020, filed 16 Feb 2021.